Recent Updates
Recently added Catalysts
STVN Positive Sentiment

Summary of Resolutions Passed at Annual General Meeting on

Wednesday, August 2, 2023 BiopharmaWatch Research 2 min read
Add on Google
Key Takeaway: On May 24, 2023, Stevanato Group S.p.A. (NYSE: STVN) held its Annual General Meeting, during which all proposed resolutions were successfully approved by shareholders. Key approvals included financial statements for the fiscal year ending December 31, 2022, and a dividend distribution of EUR 0.054 per share. Shareholders also appointed PricewaterhouseCoopers S.p.A. as the external auditor for the next three financial years and granted the board new authorization for treasury share transactions. Additionally, proposed amendments to the company's articles of association were ratified.
Price reaction · baseline $33.07 (2023-08-01 close) · hit after-hours · clean, no other STVN news in the window
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • All resolutions proposed to shareholders were passed successfully.
  • Distribution of dividends was approved.
  • The appointment of a reputable auditor was confirmed.
  • Amendments to the company's articles of association were approved.

Full Press Release Details

Summary of Resolutions Passed at Annual General Meeting on May 24, 2023
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical,
biotechnology and life sciences industries passed all resolutions proposed to Shareholders at the Annual General Meeting of Shareholders ( AGM ) held virtually on May 24, 2023.
Details of the resolutions submitted to, and approved by, the AGM are included in the explanatory report prepared by the board of directors of the Company,
which is available on the Company s corporate website at https://ir.stevanatogroup.com/.
In the ordinary part of the AGM the Shareholders
approved, among other things, the annual financial statements for the financial year ended on December 31, 2022 and the allocation of annual net profits for the year, including a distribution of dividends in the amount of EUR 0.054 for each
outstanding Class A and ordinary share of the Company, net of the treasury shares.
The Shareholders also approved the Appointment of the External
Auditor PricewaterhouseCoopers S.p.A for the auditing of the Company s and the consolidated financial statements for the financial years ending on December 31, 2023, December 31, 2024, and December 31, 2025.
In addition, the Shareholders granted to the board of directors due to the expiration of the existing authorizations a new authorization for the
purchase and the disposal of ordinary and Class A treasury shares for the period and purposes indicated in the explanatory report.
extraordinary part of the AGM, the Shareholders approved all proposed amendments to the Company s articles of association as described in the explanatory report.
Further information regarding the AGM is available on the investors section of Stevanato Group s corporate website at
https://ir.stevanatogroup.com/, including the full text of the AGM notice, explanatory report and other AGM materials.
Shareholders may request a

Frequently Asked Questions

What resolutions were passed at the AGM on May 24, 2023?

All resolutions proposed to shareholders were approved during the AGM.

What was approved regarding financial statements?

Shareholders approved the annual financial statements for the year ending December 31, 2022.

What dividend was announced at the AGM?

A dividend of EUR 0.054 per outstanding Class A and ordinary share was declared.

Who was appointed as the external auditor?

PricewaterhouseCoopers S.p.A was appointed for financial audits through 2025.

How can shareholders access AGM materials?

AGM materials can be accessed on the corporate website or requested via email.

ShareAdd on Google
Tags: STVN Stevanato Group Annual General Meeting dividends PricewaterhouseCoopers
Last updated: Aug 2, 2023